Sun Pharma bullish on specialty biz, looks to expand the segment to new geographies

Sharing information with shareholders, Sun Pharmaceutical Industries
Managing Director Dilip Shanghvi said the company's strategy of
developing the specialty business as an additional growth engine has
started delivering results, with a gradual ramp up in specialty
revenues.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-bullish-on-specialty-biz-looks-to-expand-the-segment-to-new-geographies/articleshow/78344062.cms

Comments

Popular posts from this blog

Pharma Production Executive Post Vacancy @ Intas

Pharos of Chaos

HILR Intersession: Mollie Crawford-Volk: Velazquez' "Las Meninas" and its Modern Progeny